- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02169947
Weight Loss and Maintenance for Rural, African American Communities of Faith (The WORD) (WORD)
March 28, 2018 updated by: University of Arkansas
The WORD (Wholeness, Oneness, Righteousness, Deliverance) is a faith-based weight loss study in rural, African American adults of faith.
The study will see whether a weight loss + maintenance intervention will cause participants to maintain their weight better than a weight loss only intervention.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
425
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Arkansas
-
Little Rock, Arkansas, United States, 72205
- University of Arkansas for Medical Sciences
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- African American
- Aged 18 and older
- Have a BMI ) > 25 kg/m²
- Associated with a participating church through membership or participation in a church activity
- Free of medical problems that might contraindicated participation in a behavioral weight reduction program containing an exercise component
- Individuals taking sulfonylureas who have a letter from their doctor supporting their participation in the study will be considered eligible
Exclusion Criteria
- Not had a heart attack or stroke in the past 6 months
- Not currently on medication that might affect weight loss or require medical monitoring (i.e. insulin)
- Not pregnant, not pregnant in the previous six months, or lactating
- Not enrolled in another weight reduction program
- Agree to complete the program assigned to them
- Never had weight loss surgery
- Not have lost more than 10% body weight in the previous 6 months
- Not have a clinically significant medical condition likely to impact weight or any condition that makes it unlikely the participant would be available to follow the protocol for 18 months
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Weight loss core
Participants will receive a culturally adapted version of the Diabetes Prevention Program core (16 session) program.
|
The weight loss core is a culturally adapted version of the Diabetes Prevention Program core 16 week session program.
|
|
Experimental: Weight loss core plus maintenance
Participants will receive a culturally adapted version of the Diabetes Prevention Program core (16 session) program PLUS 12 maintenance sessions.
|
The weight loss core is a culturally adapted version of the Diabetes Prevention Program core 16 week session program.
The intervention is a culturally adapted version of the Diabetes Prevention Program core 16 sessions plus 12 maintenance sessions.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Change in weight from 6 months to 18 months
Time Frame: Change from 6 months to 18 months
|
Change from 6 months to 18 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Karen Yeary, PhD, University of Arkansas
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 1, 2012
Primary Completion (Actual)
February 28, 2018
Study Completion (Actual)
February 28, 2018
Study Registration Dates
First Submitted
June 17, 2014
First Submitted That Met QC Criteria
June 19, 2014
First Posted (Estimate)
June 23, 2014
Study Record Updates
Last Update Posted (Actual)
March 29, 2018
Last Update Submitted That Met QC Criteria
March 28, 2018
Last Verified
March 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 134125
- 2P20MD002329-06 (U.S. NIH Grant/Contract)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.